These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20049467)

  • 21. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
    Auada MP; Taube MB; Collares EF; Tanaka AM; Cintra ML
    Eur J Dermatol; 2002; 12(3):263-6. PubMed ID: 11978568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
    Sarret C; Rigal M; Vaurs-Barrière C; Dorboz I; Eymard-Pierre E; Combes P; Giraud G; Wanders RJ; Afenjar A; Francannet C; Boespflug-Tanguy O
    J Neurol Sci; 2012 Jan; 312(1-2):123-6. PubMed ID: 21872273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
    Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ
    Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
    Rizzo WB; Lin Z; Carney G
    Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redefining the Sjögren-Larsson syndrome: atypical findings in three siblings and implications regarding diagnosis.
    Nigro JF; Rizzo WB; Esterly NB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):678-84. PubMed ID: 8912560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren-Larsson syndrome due to a novel mutation in the FALDH gene.
    Botelho Gomes JM; Vieira AP; Navarro J; Maré R; Tavares P; Brito C
    Eur J Dermatol; 2011; 21(3):412-3. PubMed ID: 21524986
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
    Didona B; Codispoti A; Bertini E; Rizzo WB; Carney G; Zambruno G; Dionisi-Vici C; Paradisi M; Pedicelli C; Melino G; Terrinoni A
    J Hum Genet; 2007; 52(10):865-870. PubMed ID: 17902024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large contiguous gene deletions in Sjögren-Larsson syndrome.
    Engelstad H; Carney G; S'aulis D; Rise J; Sanger WG; Rudd MK; Richard G; Carr CW; Abdul-Rahman OA; Rizzo WB
    Mol Genet Metab; 2011 Nov; 104(3):356-61. PubMed ID: 21684788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
    Rizzo WB; Carney G; Lin Z
    Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis.
    Schmuth M; Yosipovitch G; Williams ML; Weber F; Hintner H; Ortiz-Urda S; Rappersberger K; Crumrine D; Feingold KR; Elias PM
    J Invest Dermatol; 2001 Oct; 117(4):837-47. PubMed ID: 11676820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjögren-Larsson syndrome.
    Sakai K; Akiyama M; Watanabe T; Sanayama K; Sugita K; Takahashi M; Suehiro K; Yorifuji K; Shibaki A; Shimizu H
    J Invest Dermatol; 2006 Nov; 126(11):2545-7. PubMed ID: 16794583
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
    Carney G; Wei S; Rizzo WB
    Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gatekeeper helix determines the substrate specificity of Sjögren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase.
    Keller MA; Zander U; Fuchs JE; Kreutz C; Watschinger K; Mueller T; Golderer G; Liedl KR; Ralser M; Kräutler B; Werner ER; Marquez JA
    Nat Commun; 2014 Jul; 5():4439. PubMed ID: 25047030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered lipid profiles in the stratum corneum of Sjögren-Larsson syndrome.
    Nakajima K; Sano S; Uchida Y; Akiyama M; Morita Y; Shimizu H
    J Dermatol Sci; 2011 Jul; 63(1):64-6. PubMed ID: 21531120
    [No Abstract]   [Full Text] [Related]  

  • 40. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
    Willemsen MA; Cruysberg JR; Rotteveel JJ; Aandekerk AL; Van Domburg PH; Deutman AF
    Am J Ophthalmol; 2000 Dec; 130(6):782-9. PubMed ID: 11124298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.